David King, the LabCorp President & CEO sold 196,400 shares of Laboratory Corp Of America Holdings worth exactly $25,139,148 USD, at average stock price per share of $128.
By Chris Laudani – Jun 02, 2016 | 11:00 AM EDT — Laboratory Corp. of America (LH) bought contract-research firm Covance for $5.7 billion last year, and 2016 could be the year where the deal really begins to pay off. (more…)
Reuters – May 31, 2016 7:00 AM — By Lewis Krauskopf
NEW YORK, May 31 (Reuters) – Shares of Quest Diagnostics and Laboratory Corporation of America Holdings have been on a roll as analysts point to improving business trends for the U.S. clinical-lab testing industry stalwarts.
Their share gains have also come as a competitive threat from Theranos, an upstart rival in the sector, appears to have diminished. Next, the shares face a test of their own: an impending Medicare reimbursement decision.